SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000926617-22-000036
Filing Date
2022-05-18
Accepted
2022-05-17 20:44:08
Documents
12
Period of Report
2022-05-18
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K awh-20220518x8k.htm   iXBRL 8-K 71859
  Complete submission text file 0000926617-22-000036.txt   196860

Data Files

Seq Description Document Type Size
2 EX-101.SCH awh-20220518.xsd EX-101.SCH 2588
3 EX-101.LAB awh-20220518_lab.xml EX-101.LAB 15724
4 EX-101.PRE awh-20220518_pre.xml EX-101.PRE 11294
6 EXTRACTED XBRL INSTANCE DOCUMENT awh-20220518x8k_htm.xml XML 5018
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
Aspira Women's Health Inc. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34810 | Film No.: 22936744
SIC: 2835 In Vitro & In Vivo Diagnostic Substances